Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is a randomized, double-blind, sequential, dose-escalation, Phase 1 trial to evaluate the safety and tolerability of verdinexor. Verdinexor or placebo will be given on Days 1 and 3 to healthy adult participants.
Epistemonikos ID: 942d746597732d764a75cc3c85765a04bb7a48a3
First added on: May 12, 2024